Gaining myocytes or losing fibroblasts: Challenges in cardiac fibroblast reprogramming for infarct repair

Journal of Molecular and Cellular Cardiology

Volumn 93, Issue , 2016, Pages 108-114

  Nagalingam, Raghu S ^a   Safi, Hamza A ^a   Czubryt, Michael P ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cardiac fibroblasts; Extracellular matrix; Myocardial infarction; Reprogramming; Transdifferentiation

Indexed keywords

TRANSCRIPTION FACTOR GATA 4; TROPOMYOSIN; TROPONIN T;

CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; EXTRACELLULAR MATRIX; HEART EJECTION FRACTION; HEART FIBROBLAST; HEART INFARCTION; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW; ANIMAL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CYTOLOGY; FIBROBLAST; METABOLISM; NUCLEAR REPROGRAMMING; PATHOLOGY; WOUND HEALING;

ANIMALS; CELL TRANSDIFFERENTIATION; CELLULAR REPROGRAMMING; FIBROBLASTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHENOTYPE; WOUND HEALING;

EID: 84949669458     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.11.029     Document Type: Review

References (74)

1. Prevalence of coronary heart disease-United States, 2006-2010. MMWR Morb. Mortal. Wkly Rep. 2011, 60:1377-1381.
2. Mozaffarian D., Benjamin E.J., Go A.S., Arnett D.K., Blaha M.J., Cushman M., et al. Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015, 131:e29-322.
3. Porter K.E., Turner N.A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 2009, 123:255-278.
4. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142:375-386.
5. Eckhouse S.R., Spinale F.G. Changes in the myocardial interstitium and contribution to the progression of heart failure. Heart Fail. Clin. 2012, 8:7-20.
6. Shyy J.Y., Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr. Opin. Cell Biol. 1997, 9:707-713.
7. Bonnans C., Chou J., Werb Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 2014, 15:786-801.
8. Buscemi L., Ramonet D., Klingberg F., Formey A., Smith-Clerc J., Meister J.J., et al. The single-molecule mechanics of the latent TGF-beta1 complex. Curr. Biol. 2011, 21:2046-2054.
9. Klingberg F., Chow M.L., Koehler A., Boo S., Buscemi L., Quinn T.M., et al. Prestress in the extracellular matrix sensitizes latent TGF-beta1 for activation. J. Cell Biol. 2014, 207:283-297.
10. Goshima K., Tonomura Y. Synchronized beating of embryonic mouse myocardial cells mediated by FL cells in monolayer culture. Exp. Cell Res. 1969, 56:387-392.
11. Feld Y., Melamed-Frank M., Kehat I., Tal D., Marom S., Gepstein L. Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation 2002, 105:522-529.
12. Rook M.B., Jongsma H.J., de Jonge B. Single channel currents of homo- and heterologous gap junctions between cardiac fibroblasts and myocytes. Pflugers Arch. - Eur. J. Physiol. 1989, 414:95-98.
13. Vasquez C., Benamer N., Morley G.E. The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J. Cardiovasc. Pharmacol. 2011, 57:380-388.
14. Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y., et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139:2139-2149.
15. Fan D., Takawale A., Lee J., Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012, 5:15.
16. Weber K.T. Fibrosis and hypertensive heart disease. Curr. Opin. Cardiol. 2000, 15:264-272.
17. Roche P.L., Filomeno K.L., Bagchi R.A., Czubryt M.P. Intracellular signaling of cardiac fibroblasts. Compr. Physiol. 2015, 5:721-760.
18. Cleutjens J.P., Creemers E.E. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction. J. Card. Fail. 2002, 8:S344-S348.
19. Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. J. Clin. Invest. 2007, 117:568-575.
20. Hermans K.C., Daskalopoulos E.P., Blankesteijn W.M. The Janus face of myofibroblasts in the remodeling heart. J. Mol. Cell. Cardiol. 2016, (in press).
21. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 2010, 43:146-155.
22. Santiago J.J., Dangerfield A.L., Rattan S.G., Bathe K.L., Cunnington R.H., Raizman J.E., et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev. Dyn. 2010, 239:1573-1584.
23. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol. 2007, 127:526-537.
24. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Investig. 1990, 63:21-29.
25. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J. Cell Biol. 2006, 172:259-268.
26. Godbout C., Follonier Castella L., Smith E.A., Talele N., Chow M.L., Garonna A., et al. The mechanical environment modulates intracellular calcium oscillation activities of myofibroblasts. PLoS One 2013, 8:e64560.
27. MacLean J., Pasumarthi K.B. Signaling mechanisms regulating fibroblast activation, phenoconversion and fibrosis in the heart. Indian J. Biochem. Biophys. 2014, 51:476-482.
28. Souders C.A., Bowers S.L., Baudino T.A. Cardiac fibroblast: the renaissance cell. Circ. Res. 2009, 105:1164-1176.
29. Cunnington R.H., Northcott J.M., Ghavami S., Filomeno K.L., Jahan F., Kavosh M.S., et al. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype. J. Cell Sci. 2014, 127:40-49.
30. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
31. Small E., Lighthouse J.K. Transcriptional control of cardiac fibroblast plasticity. J. Mol. Cell. Cardiol. 2016, (in press).
32. McLarty J.L., Melendez G.C., Brower G.L., Janicki J.S., Levick S.P. Tryptase/Protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 2011, 58:264-270.
33. Melendez G.C., McLarty J.L., Levick S.P., Du Y., Janicki J.S., Brower G.L. Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010, 56:225-231.
34. Espira L., Lamoureux L., Jones S.C., Gerard R.D., Dixon I.M., Czubryt M.P. The basic helix-loop-helix transcription factor scleraxis regulates fibroblast collagen synthesis. J. Mol. Cell. Cardiol. 2009, 47:188-195.
35. Bagchi R.A., Czubryt M.P. Synergistic roles of scleraxis and Smads in the regulation of collagen 1alpha2 gene expression. Biochim. Biophys. Acta 2012, 1823:1936-1944.
36. Spinale F.G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007, 87:1285-1342.
37. Lindsey M.L., Iyer R.P., Jung M., DeLeon-Pennell K., Ma Y. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. J. Mol. Cell. Cardiol. 2016, (in press).
38. Moore L., Fan D., Basu R., Kandalam V., Kassiri Z. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure. Heart Fail. Rev. 2012, 17:693-706.
39. Camelliti P., Green C.R., Kohl P. Structural and functional coupling of cardiac myocytes and fibroblasts. Adv. Cardiol. 2006, 42:132-149.
40. Horn M.A., Trafford A.W. Aging and the cardiac extracellular matrix: novel mediators of fibrotic remodeling. J. Mol. Cell. Cardiol. 2016, (in press).
41. Goldsmith E.C., Hoffman A., Morales M.O., Potts J.D., Price R.L., McFadden A., et al. Organization of fibroblasts in the heart. Dev. Dyn. 2004, 230:787-794.
42. Lajiness J.D., Conway S.J. The dynamic role of cardiac fibroblasts in development and disease. J. Cardiovasc. Transl. Res. 2012, 5:739-748.
43. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J. Cell. Physiol. 2010, 225:631-637.
44. Ma Y., de Castro Bras L.E., Toba H., Iyer R.P., Hall M.E., Winniford M.D., et al. Myofibroblasts and the extracellular matrix network in post-myocardial infarction cardiac remodeling. Pflugers Arch. - Eur. J. Physiol. 2014, 466:1113-1127.
45. Czubryt M.P. Common threads in cardiac fibrosis, infarct scar formation, and wound healing. Fibrogenesis Tissue Repair 2012, 5:19.
46. Chen O., Qian L. Direct cardiac reprogramming: advances in cardiac regeneration. BioMed Res. Int. 2015, 2015:580406.
47. Sadahiro T., Yamanaka S., Ieda M. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ. Res. 2015, 116:1378-1391.
48. Christie J.D., Edwards L.B., Aurora P., Dobbels F., Kirk R., Rahmel A.O., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J. Heart Lung Transplant. 2008, 27:957-969.
49. Muraoka N., Ieda M. Direct reprogramming of fibroblasts into myocytes to reverse fibrosis. Annu. Rev. Physiol. 2014, 76:21-37.
50. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
51. Malliaras K., Marban E. Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br. Med. Bull. 2011, 98:161-185.
52. Mummery C. Induced pluripotent stem cells-a cautionary note. N. Engl. J. Med. 2011, 364:2160-2162.
53. Yamashita T., Kawai H., Tian F., Ohta Y., Abe K. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain. Cell Transplant. 2011, 20:883-891.
54. Zhang G.W., Liu X.C., Li-Ling J., Luan Y., Ying Y.N., Wu X.S., et al. Mechanisms of the protective effects of BMSCs promoted by TMDR with heparinized bFGF-incorporated stent in pig model of acute myocardial ischemia. J. Cell. Mol. Med. 2011, 15:1075-1086.
55. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
56. Jugdutt B.I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?. Circulation 2003, 108:1395-1403.
57. Gao Y., Chu M., Hong J., Shang J., Xu D. Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway. J. Thorac. Dis. 2014, 6:1458-1468.
58. Efe J.A., Hilcove S., Kim J., Zhou H., Ouyang K., Wang G., et al. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 2011, 13:215-222.
59. Protze S., Khattak S., Poulet C., Lindemann D., Tanaka E.M., Ravens U. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells. J. Mol. Cell. Cardiol. 2012, 53:323-332.
60. Jayawardena T.M., Egemnazarov B., Finch E.A., Zhang L., Payne J.A., Pandya K., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 2012, 110:1465-1473.
61. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
62. Srivastava D., Ieda M., Fu J., Qian L. Cardiac repair with thymosin beta4 and cardiac reprogramming factors. Ann. N. Y. Acad. Sci. 2012, 1270:66-72.
63. Kapur S.K., Wang X., Shang H., Yun S., Li X., Feng G., et al. Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids. Biofabrication 2012, 4:025004.
64. Willems I.E., Havenith M.G., De Mey J.G., Daemen M.J. The alpha-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 1994, 145:868-875.
65. Nam Y.J., Song K., Luo X., Daniel E., Lambeth K., West K., et al. Reprogramming of human fibroblasts toward a cardiac fate. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:5588-5593.
66. Wada R., Muraoka N., Inagawa K., Yamakawa H., Miyamoto K., Sadahiro T., et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:12667-12672.
67. Fu J.D., Stone N.R., Liu L., Spencer C.I., Qian L., Hayashi Y., et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Rep. 2013, 1:235-247.
68. Chen J.X., Krane M., Deutsch M.A., Wang L., Rav-Acha M., Gregoire S., et al. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5. Circ. Res. 2012, 111:50-55.
69. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res. 2000, 46:257-263.
70. Ju H., Zhao S., Tappia P.S., Panagia V., Dixon I.M. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation 1998, 97:892-899.
71. Romanic A.M., Burns-Kurtis C.L., Gout B., Berrebi-Bertrand I., Ohlstein E.H. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit. Life Sci. 2001, 68:799-814.
72. Holmes J.W., Clarke S.A., Richardson W.J. Modifying the mechanics of healing infarcts: is better the enemy of good?. J. Mol. Cell. Cardiol. 2016, (in press).
73. Olivetti G., Capasso J.M., Sonnenblick E.H., Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ. Res. 1990, 67:23-34.
74. Camelliti P., Borg T.K., Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005, 65:40-51.